Company Information

Company Biogenetics Co., Ltd
www.kyungnambiopharma.co.kr
Type:
SME
Country:
Korea, Republic of
Sector:
Medical equipment and services; Health care providers
Ownership:
Publicly Listed
Global Compact Status:
Non-Communicating
Participant Since
27 December 2010
Letter of Commitment
Next Communication on Progress (COP) due on:
2023 deadline to be announced (not before October 2023)

Financial Information


Communication On Progress

Published On Title Level
2021-03-17 Communication on Progress Learner
2020-03-19 Communication on Progress Learner
2019-03-19 Communication on Progress Active
2018-06-07 Communication on Progress Learner
2017-06-07 Communication on Progress Active
2016-06-15 Communication on Progress 2016 Active
2014-12-16 Communication on Progress Active
2013-12-12 Communication on Progress Active
2011-12-19 Communication on Progress Active
2011-12-19 Communication on Progress Learner

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.